KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Tax Provisions: 2019-2024

Historic Tax Provisions for Aurinia Pharmaceuticals (AUPH) over the last 6 years, with Dec 2024 value amounting to $1.7 million.

  • Aurinia Pharmaceuticals' Tax Provisions fell 17.80% to $411,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 30.72%. This contributed to the annual value of $1.7 million for FY2024, which is 183.33% up from last year.
  • Aurinia Pharmaceuticals' Tax Provisions amounted to $1.7 million in FY2024, which was up 183.33% from $600,000 recorded in FY2023.
  • In the past 5 years, Aurinia Pharmaceuticals' Tax Provisions registered a high of $1.8 million during FY2022, and its lowest value of -$94,000 during FY2020.
  • In the last 3 years, Aurinia Pharmaceuticals' Tax Provisions had a median value of $1.7 million in 2024 and averaged $1.4 million.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Tax Provisions plummeted by 165.28% in 2020, and later skyrocketed by 908.51% in 2021.
  • Aurinia Pharmaceuticals' Tax Provisions (Yearly) stood at -$94,000 in 2020, then soared by 908.51% to $760,000 in 2021, then soared by 140.53% to $1.8 million in 2022, then tumbled by 67.18% to $600,000 in 2023, then surged by 183.33% to $1.7 million in 2024.